Suppr超能文献

人类局灶性皮质发育不良中的葡萄糖转运蛋白1(GLUT1)与脑葡萄糖代谢减低和关键葡萄糖调节基因的高甲基化有关。

GLUT1 and cerebral glucose hypometabolism in human focal cortical dysplasia is associated with hypermethylation of key glucose regulatory genes.

作者信息

Ghosh Chaitali, Westcott Rosemary, Skvasik David, Khurana Ishant, Khoury Jean, Blumcke Ingmar, El-Osta Assam, Najm Imad M

机构信息

Cleveland Clinic.

Baker IDI Heart and Diabetes Institute.

出版信息

Res Sq. 2024 Oct 17:rs.3.rs-4946501. doi: 10.21203/rs.3.rs-4946501/v1.

Abstract

Focal cortical dysplasia (FCD) is recognized as a significant etiological factor in pharmacoresistant intractable epilepsy, linked with disturbances in neurovascular metabolism. Our study investigated regulation of glucose-transporter1 (GLUT1) and cerebral hypometabolism within FCD subtypes. Surgically excised human brain specimens underwent histopathological categorization. A subset of samples (paired with matching blood) was assessed for DNA methylation changes of glucose metabolism-related genes. We evaluated GLUT1, VEGFα, MCT2, and mTOR expression by western blot analysis, measured glucose-lactate concentrations, and established correlations with patients' demographic and clinical profiles. Furthermore, we investigated the impact of DNA methylation inhibitor decitabine and hypometabolic condition on the uptake of [H]-2-deoxyglucose and ATPase in epileptic brain endothelial cells (EPI-EC). We observed hypermethylation of GLUT1 and glucose metabolic genes in FCD brain/blood samples and could distinguish FCDIIa/b from mMCD, MOGHE and non-lesional types in brain. Low GLUT1 and glucose-lactate ratios corresponded to elevated VEGFα and MCT2 in FCDIIa/b vs non-lesional tissues, independent of age, gender, seizure-onset, or duration of epilepsy. Increased mTOR signaling in FCDIIa/b tissues was evident. Decitabine stimulation increased GLUT1, decreased VEGFα expression, restored glucose uptake and ATPase activity in EPI-ECs and reduced mTOR and MCT2 levels in HEK cells. We demonstrated: 1) hypermethylation of glucose regulatory genes distinguish FCDIIa/b from mMCD, MOGHE and non-lesional types, 2) glucose uptake reduction is due to GLUT1 suppression mediated possibly by a GLUT1-mTOR mechanism; and 3) DNA methylation regulates cellular glucose update and metabolism. Together, these studies may lead to GLUT1-mediated biomarkers, glucose metabolism and identify early intervention strategies in FCD.

摘要

局灶性皮质发育不良(FCD)被认为是药物难治性顽固性癫痫的一个重要病因,与神经血管代谢紊乱有关。我们的研究调查了FCD亚型中葡萄糖转运蛋白1(GLUT1)的调节和脑代谢减退情况。对手术切除的人脑标本进行组织病理学分类。对一部分样本(与匹配的血液配对)评估葡萄糖代谢相关基因的DNA甲基化变化。我们通过蛋白质印迹分析评估GLUT1、VEGFα、MCT2和mTOR的表达,测量葡萄糖 - 乳酸浓度,并建立与患者人口统计学和临床特征的相关性。此外,我们研究了DNA甲基化抑制剂地西他滨和代谢减退状态对癫痫性脑内皮细胞(EPI - EC)中[H] - 2 - 脱氧葡萄糖摄取和ATP酶的影响。我们观察到FCD脑/血样本中GLUT1和葡萄糖代谢基因的高甲基化,并且可以在脑中区分FCDIIa/b与微小发育不良性皮质病变(mMCD)、局灶性多小脑回畸形(MOGHE)和非病变类型。与非病变组织相比,FCDIIa/b中低GLUT1和葡萄糖 - 乳酸比值与升高的VEGFα和MCT2相对应,与年龄、性别、癫痫发作起始或癫痫持续时间无关。FCDIIa/b组织中mTOR信号传导增加是明显的。地西他滨刺激增加了GLUT1,降低了VEGFα表达,恢复了EPI - EC中的葡萄糖摄取和ATP酶活性,并降低了HEK细胞中的mTOR和MCT2水平。我们证明:1)葡萄糖调节基因的高甲基化将FCDIIa/b与mMCD、MOGHE和非病变类型区分开来;2)葡萄糖摄取减少是由于可能由GLUT1 - mTOR机制介导的GLUT1抑制;3)DNA甲基化调节细胞葡萄糖摄取和代谢。总之,这些研究可能会产生GLUT1介导的生物标志物、葡萄糖代谢,并确定FCD的早期干预策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a091/11527251/c83cd465e58c/nihpp-rs4946501v1-f0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验